NM_001370181.1:c.1240+17369T>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001370181.1(GSTCD):c.1240+17369T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0446 in 152,304 control chromosomes in the GnomAD database, including 209 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.045   (  209   hom.,  cov: 33) 
Consequence
 GSTCD
NM_001370181.1 intron
NM_001370181.1 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.879  
Publications
6 publications found 
Genes affected
 GSTCD  (HGNC:25806):  (glutathione S-transferase C-terminal domain containing) Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022] 
 INTS12  (HGNC:25067):  (integrator complex subunit 12) INTS12 is a subunit of the Integrator complex, which associates with the C-terminal domain of RNA polymerase II large subunit (POLR2A; MIM 180660) and mediates 3-prime end processing of small nuclear RNAs U1 (RNU1; MIM 180680) and U2 (RNU2; MIM 180690) (Baillat et al., 2005 [PubMed 16239144]).[supplied by OMIM, Mar 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84). 
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0623  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GSTCD | NM_001370181.1 | c.1240+17369T>C | intron_variant | Intron 5 of 11 | ENST00000515279.6 | NP_001357110.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0447  AC: 6799AN: 152186Hom.:  210  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6799
AN: 
152186
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.0446  AC: 6794AN: 152304Hom.:  209  Cov.: 33 AF XY:  0.0421  AC XY: 3139AN XY: 74478 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6794
AN: 
152304
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
3139
AN XY: 
74478
show subpopulations 
African (AFR) 
 AF: 
AC: 
480
AN: 
41564
American (AMR) 
 AF: 
AC: 
978
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
250
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
102
AN: 
4828
European-Finnish (FIN) 
 AF: 
AC: 
337
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
38
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
4344
AN: 
68010
Other (OTH) 
 AF: 
AC: 
141
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 338 
 676 
 1013 
 1351 
 1689 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 82 
 164 
 246 
 328 
 410 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
45
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.